Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies

M Mimeault, SK Batra - Molecular aspects of medicine, 2014 - Elsevier
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene
products involved in the epithelial–mesenchymal transition (EMT) program, altered …
被引用次数：66 相关文章

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies

M Mimeault, SK Batra - Molecular Aspects of Medicine, 2014 - experts.nebraska.edu
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene
products involved in the epithelial-mesenchymal transition (EMT) program, altered metabolic …
[HTML] nih.gov

[HTML][HTML] Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies

M Mimeault, SK Batra - Molecular aspects of medicine, 2014 - ncbi.nlm.nih.gov
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene
products involved in the epithelial-mesenchymal transition (EMT) program, altered metabolic …

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies

M Mimeault, SK Batra - Molecular Aspects of Medicine, 2014 - infona.pl
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene
products involved in the epithelial–mesenchymal transition (EMT) program, altered …

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies

M Mimeault, SK Batra - Molecular aspects of medicine, 2014 - pubmed.ncbi.nlm.nih.gov
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene
products involved in the epithelial-mesenchymal transition (EMT) program, altered metabolic …

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

M Mimeault, SK Batra - Molecular Aspects of Medicine, 2013 - europepmc.org
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene
products involved in the epithelial-mesenchymal transition (EMT) program, altered metabolic …

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

M Mimeault, SK Batra - Molecular Aspects of Medicine, 2013 - europepmc.org
Recent studies in the field of cancer stem cells have revealed that the alterations in key gene
products involved in the epithelial-mesenchymal transition (EMT) program, altered metabolic …